n-phenethylpiperidine has been researched along with ne 100 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abate, C; Berardi, F; Colabufo, NA; Contino, M; Ferorelli, S; Pedone, MP; Perrone, R | 1 |
| Abate, C; Berardi, F; Colabufo, NA; de Robertis, AF; Ferorelli, S; Leopoldo, M; Niso, M; Perrone, R | 1 |
| Mamolo, MG; Menegazzi, R; Romano, M; Zampieri, D | 1 |
3 other study(ies) available for n-phenethylpiperidine and ne 100
| Article | Year |
|---|---|
Methyl substitution on the piperidine ring of N-[omega-(6-methoxynaphthalen-1-yl)alkyl] derivatives as a probe for selective binding and activity at the sigma(1) receptor.
Topics: Animals; Cell Proliferation; Methylation; Naphthalenes; Piperidines; Radioligand Assay; Rats; Receptors, sigma; Steroid Isomerases; Structure-Activity Relationship; Tumor Cells, Cultured | 2005 |
Novel 4-(4-aryl)cyclohexyl-1-(2-pyridyl)piperazines as Delta(8)-Delta(7) sterol isomerase (emopamil binding protein) selective ligands with antiproliferative activity.
Topics: Apoptosis; Binding Sites; Cell Proliferation; Crystallography, X-Ray; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Humans; Ligands; Models, Molecular; Molecular Structure; Piperazines; Pyridines; Stereoisomerism; Steroid Isomerases; Structure-Activity Relationship; Tumor Cells, Cultured | 2008 |
New piperidine-based derivatives as sigma receptor ligands. Synthesis and pharmacological evaluation.
Topics: Cell Line, Tumor; Humans; Ligands; Piperidines; Receptors, sigma | 2018 |